MATERIAL EVENT4512.TTSE

Wakamoto Pharmaceutical: change of representative director

Summary

WAKAMOTO PHARMACEUTICAL CO., LTD. filed an extraordinary report via EDINET on 2026-03-24 15:36 JST. Reason(s) cited: extraordinary report.

Open the price chart on TradingView.

Source: EDINET S100XSP6 ↗ · PDL1.0 · Not investment advice